Share chart Schrödinger, Inc.
Extended chart
Simple chart
About Schrödinger, Inc.
SchrÃdinger, Inc. предоставляет вычислительную платформу для ускорения открытия лекарств и разработки материалов для биофармацевтических и промышленных компаний, академических институтов и государственных лабораторий по всему миру. Компания работает в двух сегментах: Software и Drug Discovery. Этот сегмент ориентирован на продажу своего программного обеспечения для открытия лекарств в отрасли наук о жизни, а также клиентам в отраслях материаловедения. more detailsMain settings
| IPO date | 2020-02-06 |
|---|---|
| ISIN | US80810D1037 |
| Industry | Health Care Technology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | link |
| Цена ао | 21.4 |
| Change price per day: | 0% (21.4) |
|---|---|
| Change price per week: | -9.17% (23.56) |
| Change price per month: | -18.1% (26.13) |
| Change price per 3 month: | -1.34% (21.69) |
| Change price per half year: | -0.2796% (21.46) |
| Change price per year: | -2.64% (21.98) |
| Change price per 3 year: | -12.69% (24.51) |
| Change price per 5 year: | -64.69% (60.61) |
| Change price per year to date: | +8.3% (19.76) |
Grade
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
Insider trading
Main owners
| Institutions | Volume | Share, % |
|---|---|---|
| Blackrock Inc. | 8 763 505 | 13.88 |
| Bill & Melinda Gates Foundation Trust | 6 981 664 | 11.06 |
| Vanguard Group Inc | 6 776 631 | 10.73 |
| ARK Investment Management, LLC | 3 053 521 | 4.84 |
| Baillie Gifford and Company | 2 602 389 | 4.12 |
| Sumitomo Mitsui Trust Holdings, Inc. | 2 300 750 | 3.64 |
| State Street Corporation | 2 055 344 | 3.25 |
| Credit Suisse Ag/ | 1 808 033 | 2.86 |
| Morgan Stanley | 1 780 197 | 2.82 |
| Nikko Asset Management Americas, Inc. | 1 359 122 | 2.15 |
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| iMGP RBA Responsible Global Allocation ETF | 7.71 | 0 | 2.39 |
| Syntax Stratified SmallCap ETF | 0.35189 | 13.51 | 1.639 |
| iShares Morningstar Small-Cap Growth ETF | 0.02858 | 595.05 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.02327 | 391.25 | 1.60498 |
| iShares Morningstar Small-Cap Value ETF | 0.01834 | 187.77 | 2.50476 |
| 1.63 | 237.52 | 1.77 |
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Karen Akinsanya Ph.D. | President of Research & Development Therapeutics | 777.68k | 1968 (57 years) |
| Prof. William Goddard III | Co-Founder & Scientific Advisor | N/A | |
| Mr. Kenneth Patrick Lorton | Executive VP, CTO & COO of Software | 510.09k | 1984 (41 year) |
| Mr. Shane Brauner | Executive VP & Chief Information Officer | N/A | 1978 (47 years) |
| Dr. Ramy Farid Ph.D. | CEO, President & Director | 1.04M | 1965 (60 years) |
| Dr. Richard A. Friesner Ph.D. | Co-Founder, Scientific Advisory Chairman and Director | 455k | 1953 (72 years) |
| Dr. Robert Lorne Abel Ph.D. | Executive VP, Chief Scientific Officer of Platform and Head of Modeling R&D | 528.37k | 1982 (43 years) |
| Dr. Geoffrey Craig Porges MBBS | Executive VP & CFO | 555.07k | |
| Dr. Margaret Han Dugan M.D. | Chief Medical Officer | 1957 (68 years) | |
| Ms. Jaren Irene Madden | Senior Vice President of Investor Relations & Corporate Affairs |
About company
Address: United States, New York, 120 West 45th Street - Open in google maps, Open in yandex maps
Website: http://www.schrodinger.com
Website: http://www.schrodinger.com
